Isoniazid Chemoprophylaxis of Latent Primary Tuberculosis: in Five Trial Centres in France from 1959 to 1969
Identifieur interne : 000D94 ( Main/Exploration ); précédent : 000D93; suivant : 000D95Isoniazid Chemoprophylaxis of Latent Primary Tuberculosis: in Five Trial Centres in France from 1959 to 1969
Auteurs : R. Debre ; S. Perdrizet [France] ; A. Lotte [France] ; M. Naveau [France] ; F. Lert [France]Source :
- International Journal of Epidemiology [ 0300-5771 ] ; 1973.
Abstract
The object of this study is to assess the effect of chemoprophylaxis applied as quickly as possible after the date of tuberculin conversion on the risk of post-primary morbidity. 2,970 subjects aged 5 to 24 years were recruited and randomly allocated to 2 groups, one receiving isoniazid for a duration of at least 5 months, the other constituting the control group. These cases were included in this prospective and longitudinal survey from 1959 to 1966. Surveillance was carried on till 1969. Thus the duration of the observation varies from 3 to 10 years. From statistical analysis carried out according to the actuarial method, the risk of tuberculous morbidity is found to be 3 times lower in those submitted to chemoprophylaxis (0,9 g per cent) than In those who did not take the drug (2.72 per cent). This study was preceded by a survey involving 5,000 cases including a majority of latent tuberculosis in subjects under 25 years. The effective action of antibacillary drugs was shown previously.
Url:
DOI: 10.1093/ije/2.2.153
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000868
- to stream Istex, to step Curation: 000867
- to stream Istex, to step Checkpoint: 000A54
- to stream Main, to step Merge: 000E08
- to stream Main, to step Curation: 000D94
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Isoniazid Chemoprophylaxis of Latent Primary Tuberculosis: in Five Trial Centres in France from 1959 to 1969</title><author><name sortKey="Debre, R" sort="Debre, R" uniqKey="Debre R" first="R." last="Debre">R. Debre</name></author><author><name sortKey="Perdrizet, S" sort="Perdrizet, S" uniqKey="Perdrizet S" first="S." last="Perdrizet">S. Perdrizet</name></author><author><name sortKey="Lotte, A" sort="Lotte, A" uniqKey="Lotte A" first="A." last="Lotte">A. Lotte</name></author><author><name sortKey="Naveau, M" sort="Naveau, M" uniqKey="Naveau M" first="M." last="Naveau">M. Naveau</name></author><author><name sortKey="Lert, F" sort="Lert, F" uniqKey="Lert F" first="F." last="Lert">F. Lert</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8CEEED700E84BA6F0EF891854B6B98F07A9542D3</idno><date when="1973" year="1973">1973</date><idno type="doi">10.1093/ije/2.2.153</idno><idno type="url">https://api.istex.fr/document/8CEEED700E84BA6F0EF891854B6B98F07A9542D3/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000868</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000868</idno><idno type="wicri:Area/Istex/Curation">000867</idno><idno type="wicri:Area/Istex/Checkpoint">000A54</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A54</idno><idno type="wicri:doubleKey">0300-5771:1973:Debre R:isoniazid:chemoprophylaxis:of</idno><idno type="wicri:Area/Main/Merge">000E08</idno><idno type="wicri:Area/Main/Curation">000D94</idno><idno type="wicri:Area/Main/Exploration">000D94</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Isoniazid Chemoprophylaxis of Latent Primary Tuberculosis: in Five Trial Centres in France from 1959 to 1969</title><author><name sortKey="Debre, R" sort="Debre, R" uniqKey="Debre R" first="R." last="Debre">R. Debre</name><affiliation><wicri:noCountry code="no comma">International Children's Centre Cháteau de Longchamp. 75.116 Paris</wicri:noCountry></affiliation></author><author><name sortKey="Perdrizet, S" sort="Perdrizet, S" uniqKey="Perdrizet S" first="S." last="Perdrizet">S. Perdrizet</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Tuberculosis and Respiratory Diseases Section of I.N.S.E.R.M., National Institute for Medical Research 3 Rue Léon-Bonnat, 75.016, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lotte, A" sort="Lotte, A" uniqKey="Lotte A" first="A." last="Lotte">A. Lotte</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Tuberculosis and Respiratory Diseases Section of I.N.S.E.R.M., National Institute for Medical Research 3 Rue Léon-Bonnat, 75.016, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="1"><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:regionArea>Requests for reprints may be addressed to Dr. A. Lotte, Tuberculosis and Respiratory Diseases Section of INSERM, National Institute of Health and Medical Research, 3 Rue Léon-Bonnat</wicri:regionArea><wicri:noRegion>3 Rue Léon-Bonnat</wicri:noRegion><wicri:noRegion>3 Rue Léon-Bonnat</wicri:noRegion></affiliation></author><author><name sortKey="Naveau, M" sort="Naveau, M" uniqKey="Naveau M" first="M." last="Naveau">M. Naveau</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Tuberculosis and Respiratory Diseases Section of I.N.S.E.R.M., National Institute for Medical Research 3 Rue Léon-Bonnat, 75.016, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Lert, F" sort="Lert, F" uniqKey="Lert F" first="F." last="Lert">F. Lert</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Tuberculosis and Respiratory Diseases Section of I.N.S.E.R.M., National Institute for Medical Research 3 Rue Léon-Bonnat, 75.016, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">International Journal of Epidemiology</title><idno type="ISSN">0300-5771</idno><idno type="eISSN">1464-3685</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1973">1973</date><biblScope unit="volume">2</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="153">153</biblScope><biblScope unit="page" to="160">160</biblScope></imprint><idno type="ISSN">0300-5771</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0300-5771</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">The object of this study is to assess the effect of chemoprophylaxis applied as quickly as possible after the date of tuberculin conversion on the risk of post-primary morbidity. 2,970 subjects aged 5 to 24 years were recruited and randomly allocated to 2 groups, one receiving isoniazid for a duration of at least 5 months, the other constituting the control group. These cases were included in this prospective and longitudinal survey from 1959 to 1966. Surveillance was carried on till 1969. Thus the duration of the observation varies from 3 to 10 years. From statistical analysis carried out according to the actuarial method, the risk of tuberculous morbidity is found to be 3 times lower in those submitted to chemoprophylaxis (0,9 g per cent) than In those who did not take the drug (2.72 per cent). This study was preceded by a survey involving 5,000 cases including a majority of latent tuberculosis in subjects under 25 years. The effective action of antibacillary drugs was shown previously.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Debre, R" sort="Debre, R" uniqKey="Debre R" first="R." last="Debre">R. Debre</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Perdrizet, S" sort="Perdrizet, S" uniqKey="Perdrizet S" first="S." last="Perdrizet">S. Perdrizet</name></region><name sortKey="Lert, F" sort="Lert, F" uniqKey="Lert F" first="F." last="Lert">F. Lert</name><name sortKey="Lotte, A" sort="Lotte, A" uniqKey="Lotte A" first="A." last="Lotte">A. Lotte</name><name sortKey="Lotte, A" sort="Lotte, A" uniqKey="Lotte A" first="A." last="Lotte">A. Lotte</name><name sortKey="Naveau, M" sort="Naveau, M" uniqKey="Naveau M" first="M." last="Naveau">M. Naveau</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= BernheimV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8CEEED700E84BA6F0EF891854B6B98F07A9542D3
|texte= Isoniazid Chemoprophylaxis of Latent Primary Tuberculosis: in Five Trial Centres in France from 1959 to 1969
}}
| This area was generated with Dilib version V0.6.33. |  |